| One year update on the COVID-19 pandemic: Where are we now? SK Mishra, T Tripathi Acta tropica 214, 105778, 2021 | 257 | 2021 |
| Design of a peptide-based subunit vaccine against novel coronavirus SARS-CoV-2 P Kalita, AK Padhi, KYJ Zhang, T Tripathi Microbial Pathogenesis 145, 104236, 2020 | 234 | 2020 |
| Current and novel therapeutic molecules and targets in Alzheimer's disease A Kumar, CM Nisha, C Silakari, I Sharma, K Anusha, N Gupta, P Nair, ... Journal of the Formosan Medical Association 115 (1), 3-10, 2016 | 180 | 2016 |
| Molecular Docking and In Silico ADMET Study Reveals Acylguanidine 7a as a Potential Inhibitor of β‐Secretase CM Nisha, A Kumar, P Nair, N Gupta, C Silakari, T Tripathi, A Kumar Advances in bioinformatics 2016 (1), 9258578, 2016 | 162 | 2016 |
| Aminoacyl-tRNA synthetases: Structure, function, and drug discovery V Rajendran, P Kalita, H Shukla, A Kumar, T Tripathi International journal of biological macromolecules 111, 400-414, 2018 | 140 | 2018 |
| Molecular dynamics simulation of protein and protein–ligand complexes R Shukla, T Tripathi Computer-aided drug design, 133-161, 2020 | 136 | 2020 |
| An efficient protocol to enhance recombinant protein expression using ethanol in Escherichia coli G Chhetri, P Kalita, T Tripathi MethodsX 2, 385-391, 2015 | 129 | 2015 |
| Muscarinic and nicotinic acetylcholine receptor agonists: current scenario in Alzheimer's disease therapy S Verma, A Kumar, T Tripathi, A Kumar Journal of Pharmacy and Pharmacology 70 (8), 985-993, 2018 | 124 | 2018 |
| Proteomic and metabolomic approaches to biomarker discovery HJ Issaq, TD Veenstra Academic Press, 2019 | 89 | 2019 |
| Unraveling the mechanism of arbidol binding and inhibition of SARS-CoV-2: Insights from atomistic simulations AK Padhi, A Seal, JM Khan, M Ahamed, T Tripathi European journal of pharmacology 894, 173836, 2021 | 86* | 2021 |
| High-throughput rational design of the remdesivir binding site in the RdRp of SARS-CoV-2: implications for potential resistance AK Padhi, R Shukla, P Saudagar, T Tripathi Iscience 24 (1), 2021 | 84* | 2021 |
| Frontiers in protein structure, function, and dynamics DB Singh, T Tripathi Springer, 2020 | 76 | 2020 |
| Development of multi-epitope driven subunit vaccine against Fasciola gigantica using immunoinformatics approach P Kalita, DL Lyngdoh, AK Padhi, H Shukla, T Tripathi International journal of biological macromolecules 138, 224-233, 2019 | 76 | 2019 |
| Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase R Shukla, H Shukla, A Sonkar, T Pandey, T Tripathi Journal of Biomolecular Structure and Dynamics 36 (8), 2045-2057, 2018 | 74 | 2018 |
| Amyloid cross-seeding: Mechanism, implication, and inhibition S Subedi, S Sasidharan, N Nag, P Saudagar, T Tripathi Molecules 27 (6), 1776, 2022 | 70 | 2022 |
| Can SARS-CoV-2 accumulate mutations in the S-protein to increase pathogenicity? AK Padhi, T Tripathi ACS Pharmacology & Translational Science 3 (5), 1023-1026, 2020 | 69 | 2020 |
| Distant Phe345 mutation compromises the stability and activity of Mycobacterium tuberculosis isocitrate lyase by modulating its structural flexibility H Shukla, R Shukla, A Sonkar, T Pandey, T Tripathi Scientific reports 7 (1), 1058, 2017 | 65 | 2017 |
| Accelerating COVID-19 research using molecular dynamics simulation AK Padhi, SL Rath, T Tripathi The Journal of Physical Chemistry B 125 (32), 9078-9091, 2021 | 64 | 2021 |
| Autophagy modulation as a treatment of amyloid diseases Z Mputhia, E Hone, T Tripathi, T Sargeant, R Martins, P Bharadwaj Molecules 24 (18), 3372, 2019 | 64 | 2019 |
| Molecular dynamics simulation in drug discovery: opportunities and challenges R Shukla, T Tripathi Innovations and implementations of computer aided drug discovery strategies …, 2021 | 63 | 2021 |
Rohit ShuklaUniversity of South Floridausf.edu의 이메일 확인됨